Dr. Roberto Pili, MD
Claim this profileIndiana University/ Melvin and Bren Simon Cancer Center
Area of expertise
Prostate Cancer
Roberto Pili, MD has run 3 trials for Prostate Cancer.
Bladder Cancer
Roberto Pili, MD has run 2 trials for Bladder Cancer. Some of their research focus areas include:
Affiliated Hospitals
Indiana University/Melvin And Bren Simon Cancer Center
University At Buffalo / Great Lakes Cancer Care
Clinical Trials Roberto Pili, MD is currently running
Immunotherapy + Chemotherapy
for Bladder Cancer
Upon successful screening and registration, enrollment to durvalumab monotherapy (cohort 1) will begin. If DLT criteria outlined in the protocol are exceeded with durvalumab monotherapy (cohort 1), the study will close. Provided the safety of durvalumab monotherapy is established, enrollment to combination regimen cohorts will proceed. Cohorts will simultaneously enroll in parallel to each other with patients assigned to cohorts based on patient slot availability and study site choice of radiation arm participation. Patient assignment to future phase 1 arms would proceed similarly. Within BCG-containing cohorts, treatment will begin at full-dose BCG. If DLT criteria outlined in Section 5.1.4 are exceeded with full-dose BCG, a one level dose reduction of BCG will be implemented. If DLT criteria outlined in Section 5.1.4 are exceeded with reduced-dose BCG, the BCG-containing cohort will not proceed to Phase 2 of the study. Similarly, if DLT criteria outlined in Section 5.1.4 are exceeded within non-BCG containing cohorts, the non-BCG containing cohort will not proceed to phase 2 of the study. Due to the prolonged half-life of antibody therapies, no dose adjustments are planned for durvalumab in any of the cohorts.
Recruiting
1 award
Phase 1 & 2
6 criteria
Caloric Restriction and Plant-Based Diet
for Cancer
Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternate days before the chemotherapy administration to enhance the cytotoxic effect generated by standard treatment of cancer.
Recruiting
1 award
N/A
More about Roberto Pili, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Roberto Pili, MD has experience with
- Docetaxel
- Gemcitabine
- Intermittent Fasting
- Tremelimumab
- External Beam Radiotherapy (EBRT)
- Durvalumab
Breakdown of trials Roberto Pili, MD has run
Prostate Cancer
Bladder Cancer
Transitional Cell Carcinoma
Integrative Oncology
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roberto Pili, MD specialize in?
Roberto Pili, MD focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Roberto Pili, MD currently recruiting for clinical trials?
Yes, Roberto Pili, MD is currently recruiting for 4 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Roberto Pili, MD has studied deeply?
Yes, Roberto Pili, MD has studied treatments such as Docetaxel, Gemcitabine, Intermittent Fasting.
What is the best way to schedule an appointment with Roberto Pili, MD?
Apply for one of the trials that Roberto Pili, MD is conducting.
What is the office address of Roberto Pili, MD?
The office of Roberto Pili, MD is located at: Indiana University/ Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University/ Melvin and Bren Simon Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.